<- Go Home

RaySearch Laboratories AB (publ)

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; and machine learning and liver ablation solutions. It has collaboration with Vision RT for integration of MapRT with RayStation treatment planning system. The company was founded in 2000 and is headquartered in Stockholm, Sweden.

Market Cap

SEK 7.7B

Volume

139.0K

Cash and Equivalents

SEK 407.3M

EBITDA

SEK 359.7M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

SEK 1.2B

Profit Margin

92.42%

52 Week High

SEK 373.50

52 Week Low

SEK 166.80

Dividend

1.79%

Price / Book Value

7.79

Price / Earnings

33.71

Price / Tangible Book Value

18.00

Enterprise Value

SEK 7.7B

Enterprise Value / EBITDA

17.71

Operating Income

SEK 329.6M

Return on Equity

24.47%

Return on Assets

10.09

Cash and Short Term Investments

SEK 407.3M

Debt

SEK 394.8M

Equity

SEK 985.3M

Revenue

SEK 1.3B

Unlevered FCF

SEK 93.4M

Sector

Health Care Technology

Category

N/A

Company Stock Pitches